173 related articles for article (PubMed ID: 11728258)
1. Global impact of stroke.
Chalmers J
Heart Dis; 2000; 2(2):S13-7. PubMed ID: 11728258
[TBL] [Abstract][Full Text] [Related]
2. PROGRESS - Perindopril Protection Against Recurrent Stroke Study: characteristics of the study population at baseline. Progress Management Committee.
J Hypertens; 1999 Nov; 17(11):1647-55. PubMed ID: 10608480
[TBL] [Abstract][Full Text] [Related]
3. PROGRESS--perindopril protection against recurrent stroke study: status in July 1996. PROGRESS Management Committee.
J Hypertens Suppl; 1996 Dec; 14(6):S47-51. PubMed ID: 9023716
[TBL] [Abstract][Full Text] [Related]
4. PROGRESS (Perindopril Protection Against Recurrent Stroke Study): regional characteristics of the study population at baseline. PROGRESS Management Committee.
Chalmers J; Neal B; MacMahon S;
J Hypertens Suppl; 2000 May; 18(1):S13-9. PubMed ID: 10939785
[TBL] [Abstract][Full Text] [Related]
5. Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration.
J Hypertens; 1998 Feb; 16(2):127-37. PubMed ID: 9535138
[TBL] [Abstract][Full Text] [Related]
6. Effects of antihypertensive drug treatment on the risk of dementia and cognitive impairment.
Poon IO
Pharmacotherapy; 2008 Mar; 28(3):366-75. PubMed ID: 18294116
[TBL] [Abstract][Full Text] [Related]
7. [Hypertension in the acute phase and in the secondary prevention of stroke].
Arquizan C
Rev Prat; 2004 Mar; 54(6):637-40. PubMed ID: 15222615
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: results from ADVANCE in context of available evidence.
Chalmers J; Joshi R; Kengne AP; Ninomiya T; Bi Y; Bompoint S; Billot L; Patel A;
J Hypertens Suppl; 2008 Sep; 26(3):S21-7. PubMed ID: 19363849
[TBL] [Abstract][Full Text] [Related]
9. Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy.
Dufouil C; Chalmers J; Coskun O; Besançon V; Bousser MG; Guillon P; MacMahon S; Mazoyer B; Neal B; Woodward M; Tzourio-Mazoyer N; Tzourio C;
Circulation; 2005 Sep; 112(11):1644-50. PubMed ID: 16145004
[TBL] [Abstract][Full Text] [Related]
10. Stroke secondary prevention and blood pressure reduction: an observational study of the use of PROGRESS therapy.
Bugnicourt JM; Chillon JM; Canaple S; Lamy C; Godefroy O
Fundam Clin Pharmacol; 2008 Apr; 22(2):217-22. PubMed ID: 18353116
[TBL] [Abstract][Full Text] [Related]
11. [Hypertension, heart failure, myocardial infarction, secondary prevention: the role of perindopril].
Rapezzi C; Ciliberti P; Graziosi M; Riva L
Ital Heart J; 2005 Nov; 6 Suppl 7():40S-47S. PubMed ID: 16485516
[TBL] [Abstract][Full Text] [Related]
12. An economic evaluation of a perindopril-based blood pressure lowering regimen for patients who have suffered a cerebrovascular event.
Tavakoli M; Pumford N; Woodward M; Doney A; Chalmers J; MacMahon S; Macwalter R
Eur J Health Econ; 2009 Feb; 10(1):111-9. PubMed ID: 18446392
[TBL] [Abstract][Full Text] [Related]
13. Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome.
Leenen FH
Can J Cardiol; 2004 Aug; 20 Suppl B():77B-82B. PubMed ID: 15309209
[TBL] [Abstract][Full Text] [Related]
14. Making PROGRESS in stable patients post stroke or transient ischaemic attack: implications for general practice.
Jackson G
Int J Clin Pract; 2003 Jun; 57(5):385-7. PubMed ID: 12846342
[TBL] [Abstract][Full Text] [Related]
15. Aggressive blood pressure control and stroke prevention: role of calcium channel blockers.
Papadopoulos DP; Papademetriou V
J Hypertens; 2008 May; 26(5):844-52. PubMed ID: 18398322
[TBL] [Abstract][Full Text] [Related]
16. [Effects of blood pressure lowering treatment on stroke recurrence in patients with cerebrovascular diseases-a large-scale, randomized, placebo controlled trial].
Liu LS; Gong LS; Wang W;
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Jul; 33(7):613-7. PubMed ID: 16080808
[TBL] [Abstract][Full Text] [Related]
17. Blood pressure lowering in PROGRESS (Perindopril Protection Against Recurrent Stroke Study) and white matter hyperintensities: should this progress matter to patients?
Schiffrin EL
Circulation; 2005 Sep; 112(11):1525-6. PubMed ID: 16157782
[No Abstract] [Full Text] [Related]
18. [PROGRESS].
Hasegawa Y
Nihon Rinsho; 2006 Aug; 64 Suppl 6():396-401. PubMed ID: 16983776
[No Abstract] [Full Text] [Related]
19. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease.
Tzourio C; Anderson C; Chapman N; Woodward M; Neal B; MacMahon S; Chalmers J;
Arch Intern Med; 2003 May; 163(9):1069-75. PubMed ID: 12742805
[TBL] [Abstract][Full Text] [Related]
20. Blood pressure reduction and risk of dementia in patients with stroke: rationale of the dementia assessment in PROGRESS (Perindopril Protection Against Recurrent Stroke Study). PROGRESS Management Committee.
Tzourio C; Anderson C;
J Hypertens Suppl; 2000 May; 18(1):S21-4. PubMed ID: 10939786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
